When tested for the ability to stimulate allogeneic CD4+ T cells (Fig. 4C) and CD8+ T cells (data not shown), mature MDDC prepared from cryopreserved PBMC of cancer patients (five breast cancer and two colon cancer patients) were not significantly different from those of healthy donors. This evidence concerns the gene CD8A and colonic neoplasm.